NCT06550882View on ClinicalTrials.gov

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

RecruitingOBSERVATIONAL

Enrollment

9

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Acquired Hemophilia A

Interventions

DRUG

OBIZUR

OBIZUR injection.

Trial Locations (1)

05278

RECRUITING

Kyung Hee University Hospital at Gangdong, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY